ScholarIQanswers from OpenAlex

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism

PaperCitations, authors & open-access status

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism have?

ScholarIQcitation count

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism has 275 citations in the OpenAlex counts ScholarIQ stores.

When was Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism published?

ScholarIQyear

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism has 2003 year in the ScholarIQ index.

What is the open-access status of Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism?

ScholarIQoa status

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism has closed oa status in the ScholarIQ index.

What is the DOI of Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism?

ScholarIQdoi

The DOI for Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism is on the source record.

What is the PMID of Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism?

ScholarIQpmid

The PMID for Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism is on the source record.

What is the OpenAlex record for Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism?

ScholarIQopenalex

The OpenAlex for Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial